Fidia S.p.A. (BIT:FDA)
0.2830
-0.0058 (-2.01%)
Aug 13, 2025, 5:38 PM CET
Fidia Employees
Fidia had 159 employees as of December 31, 2024. The number of employees decreased by 34 or -17.62% compared to the previous year.
Employees
159
Change (1Y)
-34
Growth (1Y)
-17.62%
Revenue / Employee
$110,277
Profits / Employee
-$58,478
Market Cap
2.11M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 159 | -34 | -17.62% |
Dec 31, 2023 | 193 | -4 | -2.03% |
Dec 31, 2022 | 197 | -20 | -9.22% |
Dec 31, 2021 | 217 | -54 | -19.93% |
Dec 31, 2020 | 271 | -42 | -13.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Leonardo S.p.a. | 60,468 |
Poste Italiane | 125,097 |
Prysmian | 31,857 |
Fincantieri | 22,586 |
Iveco Group | 36,046 |
Interpump Group | 9,357 |
Webuild | 43,573 |
Maire | 9,739 |
Fidia News
- 17 hours ago - More than 20 GOP attorneys general call on RFK Jr, FDA to reinstate safeguards for abortion drugs - Fox News
- 17 hours ago - Inovio aims for BLA submission and FDA file acceptance by year-end 2025 as 3107 data shows sustained surgery reduction - Seeking Alpha
- 1 day ago - FDA Grants 510(k) Clearance for Sonic Incytes’ Velacur ONE™, AI-Guided Point of Care Ultrasound for the Management of Chronic Liver Diseases - Financial Post
- 1 day ago - FDA may pull authorization of Pfizers Covid vaccine for children under 5 - CNBC
- 1 day ago - Why Is Liquidia Stock Trading Higher On Tuesday? - Benzinga
- 1 day ago - FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease - Benzinga
- 1 day ago - CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency - Benzinga
- 1 day ago - Veru outlines Phase III plans for enobosarm and signals upcoming FDA clarity on lean mass preservation in obesity treatment - Seeking Alpha